Efficacy of N -methyl- D -aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
Dysfunction of the -methyl- -aspartate glutamate receptor is involved in the putative pathology of schizophrenia. There is growing interest in the potential of -methyl- -aspartate receptor modulators to improve the symptoms of schizophrenia, but the evidence for the use of glutamatergic agents for a...
Saved in:
Published in | Journal of psychopharmacology (Oxford) Vol. 35; no. 3; p. 236 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.03.2021
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!